What is CompleWare?
CompleWare operates within the clinical trial services sector, focusing on ophthalmology, respiratory, and oncology therapeutic areas. The company collaborates with Contract Research Organizations (CROs), pharmaceutical firms, and biotech companies to provide dependable endpoint services essential for clinical trials. At its core, CompleWare leverages an innovative, cloud-based software solution that ensures real-time data access and maintains compliance irrespective of geographical boundaries. This technological approach is designed to accelerate the development of new therapeutic options for patients globally.
How much funding has CompleWare raised?
CompleWare has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for CompleWare?
The recent major strategic investment in CompleWare signals a transition into a significant growth phase, likely moving beyond its initial development stages towards scaling operations and expanding market reach. This capital infusion is expected to fuel further innovation in their cloud-based endpoint services, potentially enhancing their offerings in ophthalmology, respiratory, and oncology trials. Investors are likely anticipating an acceleration in market penetration and a strengthening of partnerships with CROs and pharmaceutical giants, aiming to solidify CompleWare's position as a key player in global clinical trial support.
See full CompleWare company page
